U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Cardiology, Hematology, Endocrinology and Nephrology - Division of Non-Malignant Hematology (DNH)
  1. CDER Offices and Divisions

Office of Cardiology, Hematology, Endocrinology and Nephrology - Division of Non-Malignant Hematology (DNH)

The Division of Non-Malignant Hematology (DNH) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of non-malignant hematology. Contact Us

Contact Us

Mailing Address: 

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Non-Malignant Hematology
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4177
Phone: (301) 796-2240
Fax: (301) 796-9838

 Resources



Back to Top